Enoxaparin is safe and effective for restoring and preserving forward portal venous flow in children with end-stage liver disease

J Hepatol. 2023 Feb;78(2):e57-e59. doi: 10.1016/j.jhep.2022.11.001. Epub 2022 Nov 9.

Authors

Shreya B Kishore¹, Peter Lewindon², Charlton Noble², Fariha Balouch²

Affiliations

¹ Department of Gastroenterology, Hepatology and Liver Transplantation, Queensland Children's Hospital, Brisbane, Queensland, Australia. Electronic address: shreya_bhushan@hotmail.com.
² Department of Gastroenterology, Hepatology and Liver Transplantation, Queensland Children's Hospital, Brisbane, Queensland, Australia.

PMID: 36370953
DOI: 10.1016/j.jhep.2022.11.001

No abstract available

Publication types

Letter
Comment

MeSH terms

Anticoagulants / adverse effects
Child
End Stage Liver Disease*
Enoxaparin* / adverse effects
Humans
Portal Vein

Substances

Enoxaparin
Anticoagulants